Vascular endothelial cell-specific disruption of the profilin1 gene leads to severe multiorgan pathology and

Abigail Allen-Gondringer1, David Gau1, Christopher Varghese1

  • 1Bioengineering, University of Pittsburgh, Pittsburgh, PA 15219, USA.

PNAS Nexus
|October 2, 2023
PubMed

Insights

Loss of Profilin1 (Pfn1) in endothelial cells causes severe health issues and inflammation, highlighting its critical role in mammalian survival. This study reveals Pfn1

Area of Science:

  • Cell Biology
  • Immunology
  • Developmental Biology

Background:

  • Profilin1 (Pfn1) regulates actin dynamics and is crucial for embryonic development.
  • The role of endothelial Pfn1 in adult physiology and disease remains largely unexplored.

Purpose of the Study:

  • To investigate the in vivo consequences of Pfn1 loss-of-function specifically in vascular endothelial cells (ECs).
  • To elucidate the impact of endothelial Pfn1 deficiency on cellular pathologies and immune responses.

Main Methods:

  • Generation of a mouse model with tamoxifen-inducible, EC-selective Pfn1 knockout (Pfn1EC-KO).
  • Analysis of health complications, organ pathologies, and immune cell profiles following Pfn1 ablation in ECs.
  • Assessment of cytokine/chemokine gene expression and key signaling pathway activation (IRF7, STAT1) in ECs and macrophages.

Main Results:

  • Pfn1 ablation in adult ECs led to severe pathologies including cell death, infarcts, fibrosis, and reduced survival within 3 weeks.
  • Endothelial Pfn1 deficiency promoted a proinflammatory immune environment, characterized by myeloid cell bias and elevated cytokines.
  • Pfn1 depletion in ECs directly upregulated inflammatory gene expression and potentiated paracrine inflammatory signaling to macrophages, involving IRF7 and STAT1 activation.

Conclusions:

  • Endothelial Pfn1 is indispensable for mammalian survival, with its loss triggering significant immunological consequences.
  • Pfn1 plays a critical role in maintaining endothelial integrity and suppressing inflammation, unlike its tolerable loss in other cell types.
  • Targeting endothelial Pfn1 may offer therapeutic strategies for inflammatory diseases.